Stephen Mandel’s Argan AGX Stock Holding History

Stephen Mandel’s Portfolio AGX Stock Details AGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$294M	Sell	368,673 -24,461	-6%	-$16.3M	1.8%	23
2026 Q1	$214M	Buy	+393,134	New	+$160M	1.71%	25

Other funds holding AGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Stephen Mandel's AGX Position: Q2 2026 in Review

Stephen Mandel reduced its Argan (AGX) stake by 6.2% in Q2 2026, selling an estimated $16.3M and leaving 368,673 shares worth $294M. The position accounts for 1.8% of the portfolio, ranked #23.

Stephen Mandel first reported a position in AGX in Q1 2026 and has held it in 2 quarters since. 561 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

Stephen Mandel held 368,673 shares of Argan worth $294M as of Q2 2026.
Stephen Mandel sold 24,461 Argan shares in Q2 2026, an estimated $16.3M.
Argan made up 1.8% of Stephen Mandel's portfolio in Q2 2026, its #23 holding.
Stephen Mandel first reported a position in Argan in Q1 2026 and has held it in 2 quarters since.
561 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Lone Pine Capital's 13F filing for Q2 2026, filed 14 Aug 2026.